Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT07034326 | Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer | PHASE2 | RECRUITING | 405 | — | — | Jan 1, 2025 | Dec 31, 2028 | Jun 24, 2025 | 1 | China |
Time from random start to first recurrence or death.
| Arm | Type | Description |
|---|---|---|
| Electroacupuncture combined with immunotherapy | EXPERIMENTAL | - |
| Zilongjin tablet combined with immunotherapy | EXPERIMENTAL | - |
| Immunotherapy | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Electroacupuncture combined with immunotherapy | OTHER | Connect the electroacupuncture therapy instrument, select the density wave 2 Hz/100 Hz, the current intensity should be tolerated by the patient, leave the needle for 20 min.Immunotherapy including but not limited to pabolizumab and attilizumab were repeated every 21 days for treatment weeks.The period is 1 year, and maintenance treatment can be carried out in accordance with the drug instructions and guidelines. |
| Zilongjin tablet combined with immunotherapy | DRUG | Take Zilongjin tablets orally, 4 tablets each time, 3 times a day.Immunotherapy including but not limited to pabolizumab and attilizumab were repeated every 21 days for treatment weeks.The period is 1 year, and maintenance treatment can be carried out in accordance with the drug instructions and guidelines. |
| Immunotherapy | DRUG | Immunotherapy including but not limited to pabolizumab and attilizumab were repeated every 21 days for treatment weeks.The period is 1 year, and maintenance treatment can be carried out in accordance with the drug instructions and guidelines. |
Inclusion Criteria: * (1) Non-tumor patients with stage Ⅱ, ⅢA, ⅢB (N2) non-small cell lung cancer diagnosed by pathology or cytology after surgery; (2) driver mutations negative patients; (3) Postoperative adjuvant chemotherapy was received for 1 to 4 cycles;(4)conforms to two qi syndrome of tradit...